Analysis of the systemic inflammation and the renin-angiotensin system activity in patients with arrhythmias
Article Sidebar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Main Article Content
https://orcid.org/0000-0001-6577-1576
Abstract
The aim –to compare the systemic inflammation activity and the state of renin-angiotensin system in patients with paroxysmal and persistent forms of atrial fibrillation and flutter that are associated to arterial hypertension and their effect on sympathetic nervous system activation.
Materials and methods. 147 patients were involved into the study. 103 of them had rhythm disorders. Patients with arrhythmias were divided into three main groups depending on the form and type of arrhythmia. Control groups included patients with arterial hypertension, but without studied arrhythmias, and practically healthy people. The activity of systemic inflammation was determined by the level of highly sensitive C-reactive protein in blood serum. Expression of the renin-angiotensin system activity – according to the angiotensin-converting enzyme activity. Patients underwent Holter electrocardiogram monitoring to register the heart rhythm and it’s variability.
Results. Among patients with rhythm disorders, statistically higher levels of CRP and ACE were recorded compared to patients of control groups. The highest rates were in the group of patients with a persistent form of atrial fibrillation. According to the results of the Holter ECG, a significant mathematical difference was recorded between the average heart rate and SDNN in patients with arrhythmias and a tendency to increase the maximum heart rate.
Conclusions. It was detected that in patients with atrial fibrillation and flutter on the background of arterial hypertension, compared to patients with hypertension without rhythm disturbances or healthy people, there is a higher intensity of systemic inflammation and increased activity of the renin-angiotensin system and, as a result, activation of the sympathoadrenal system.
Article Details
Keywords:
References
Derzhavna sluzhba statystyky/ http://www.ukrstat.gov.ua/. Ukrainian.
Bo Yu, Ping Yang, Xuebi Xu, Lufei Shao. C-reactive protein for predicting all-cause mortality in patients with acute ischemic stroke: a meta-analysis. Bioscience Reports. Biosci Rep. 2019;39(2):BSR20181135. https://doi.org/10.1042/BSR20181135
Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. Int J Stroke. 2021 Feb;16(2):217-21. https://doi.org/10.1177/1747493019897870
Goldsmith SR. Interactions between the sympathetic nervous system and the RAAS in heart failure. Curr Heart Fail Rep. 2004 Jul;1(2):45-50. https://doi.org/10.1007/s11897-004-0024-5
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomström-Lundqvist C, Boriani G, Castella M, Dan G, Dilaveris P, Fauchier L, Filippatos G, Kalman J, Meir M, Lane D, Lebeau JP, Lettino M, Lip G, Pinto F, Thomas GN, Valgimigli M, Gelder I, Putte B, Watkins C. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021 1 Feb;42(5):373-498. https://doi.org/10.1093/eurheartj/ehaa612
Jaberansari MT, Baxter GF, Muller CA, Latouf SE. Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium. J Amer Coll Cardiol. 2001 1 June;37(7):1996-2001. https://doi.org/10.1016/S0735-1097(01)01232-3
Koniari I, Artopoulou E, Mplani V, Mulita F, Alexopoulou E, Chourdakis E, Abo-Elseoud M, Tsigkas G, Panagiotopoulos I, Kounis N, Velissaris D. Atrial fibrillation in heart failure patients: An update on renin-angiotensin-aldosterone system pathway blockade as a therapeutic and prevention target. Cardiol J. 2023;30(2):312-26. https://doi.org/10.5603/CJ.a2022.0061
Lazzerini PE, Laghi-Pasini F, Acampa M, Srivastava U. Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6-Mediated Changes in Connexin Expression. J Amer Heart Ass. https://doi.org/10.1161/JAHA.118.011006
Dzeshka MS, Shantsila A, Shantsila E, Lip GYH. Recent Advances Atrial Fibrillation and Hypertension. Hypertension. 2017;70:854-61. https://doi.org/10.1161/hypertensionaha.117.08934
Liu T, Li G, Li L, Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol. 2007 Apr 17;49(15):1642-8. https://doi.org/10.1016/j.jacc.2006.12.042
Cainzos-Achirica M, Miedema MD, et al. The Prognostic Value of High Sensitivity C-Reactive Protein in a Multi-Ethnic Population After More Than 10 Years of Follow-Up: The Multi-Ethnic Study of Atherosclerosis (MESA). Int J Cardiol. 2018 Aug 1;264:158-64. https://doi.org/10.1016/j.ijcard.2018.02.027
Nso N, Bookani KR, Metzl M, Radparvar F. Role of inflammation in atrial fibrillation: A comprehensive review of current knowledge. J Arrhythm. 2020 Dec 23;37(1):1-10. https://doi.org/10.1002/joa3.12473
Verdecchia P, Angeli F, Reboldi G. Hypertension and Atrial Fibrillation Doubts and Certainties From Basic and Clinical Studies. Circulation Res. 2018;122(2):352-68. https://doi.org/10.1161/circresaha.117.311402
Talaieva T, Sychov O, Marchenko O, Tretyak I, et al. Subpopulations of lymphocytes and monocytes in blood of patients with atrial fibrillation or atrial flutter associated with hypertension. Cell and Organ Transplantology. 2022;10(2):74-9. https://doi.org/10.22494/cot.v10i2.141
Tetsuji Shinohara, Naohiko Takahashi. High-Sensitivity C-Reactive Protein and Bleeding Events in Atrial Fibrillation Patients Treated With Direct Oral Anticoagulants. Circulation J. https://doi.org/10.1253/circj.CJ-20-0061
Tsuda K. Renin-Angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension. Int J Hypertens. 2012;2012:474870. https://doi.org/10.1155/2012/474870
Xiao HD, Fuchs S, Campbell DJ, et al. Mice with Cardiac-Restricted Angiotensin-Converting Enzyme (ACE) Have Atrial Enlargement, Cardiac Arrhythmia, and Sudden Death. Amer J Pathology. 165(3):1019-32. https://doi.org/10.1016/S0002-9440(10)63363-9
Xue-Dong Wang, Jing Liu, Yu-Chen Zhang, et al. Correlation between the elevated uric acid levels and circulating renin-angiotensin-aldosterone system activation in patients with atrial fibrillation. Cardiovasc Diagnosis and Therapy. 2021 Feb;11(1):50-5. https://doi.org/10.21037/cdt-20-830
Zhixiang Yu, Dong Zhang, Qiuhe Ji, et al. Inhibition of the renin-angiotensin-aldosterone system prevents and cures atrial fibrillation. Medicine (Baltimore). 2021 May 7;100(18):e25559. https://doi.org/10.1097/MD.0000000000025559